MOSCOW (MRC) -- Evonik Industries, the German specialty chemicals company, is significantly expanding its global isophorone (IP) and isophorone diamine (IPD) capacities by funding an investment of more than EUR100 million in Shanghai, China, as per the company's press release.
The new production plants will be completed in the first quarter of 2014 and will increase the total capacities of IP and IPD significantly.
"We're investing in China, because we are committed to the growth region Asia. As a world leader in isophorone-based products, we will continue to further consolidate and expand our position in this chemistry," says Dr. Ulrich Kusthardt, President of Evonik’s Coating & Additives Business Unit.
With the Group’s expansion strategy it aims to support the growth ambitions of key customers in Asia and around the world. Proximity to consumers in this growing market will translate into improved local service, shorter lead times, and faster responses to changes in demand.
As MRC informed previously, this summer, Evonik Industries launched its Composites Project House, based primarily in Marl, with a branch in Darmstadt, to develop new materials and system solutions for the lightweight construction sector. This is Evonik’s tenth project house. Among the topics addressed will be automotive and aviation applications and applications in the domain of renewable energies.
Evonik, the industrial group from Germany, is one of the world leaders in specialty chemicals. Profitable growth and a sustained increase in the value of the company form the heart of Evonik’s corporate strategy. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik is active in over 100 countries around the world. The group is a global market leader in isophorone chemistry with production facilities in Herne, Marl (Germany), Mobile, Alabama (USA) and Antwerp (Belgium). Its products are known worldwide under the brand names of VESTAMIN, VESTANAT, VESTAGON and VESTASOL.
MRC